Gene · 9900
Papers2,078
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,078
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dose reduction for synaptic density PET imaging in Parkinson's disease. | Neuroimage | 2026 | 41833889 | PubTator, text mining | PubMed |
| Neuronal and glial networks interact with traumatic brain injury to modulate cognition in ABCD study. | NPJ Syst Biol Appl | 2026 | 41826372 | PubTator, text mining | PubMed |
| Variance reduction with synaptic density imaging in Parkinson's disease using direct-4D PET image reconstruction. | Phys Med Biol | 2026 | 41825140 | PubTator, text mining | PubMed |
| Advances in calcium signalling research for the diagnosis and treatment of depression. | Ann Med | 2026 | 41787814 | PubTator, text mining | PubMed |
| Cognitive and Behavioral Effects of Levetiracetam in Juvenile Rats. | Pharmacol Res Perspect | 2026 | 41786654 | PubTator, text mining | PubMed |
| SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study. | Proc Natl Acad Sci U S A | 2026 | 41774796 | PubTator, text mining | PubMed |
| Seletracetam Revisited: A Missed Opportunity for Effective Epilepsy Therapy. | CNS Drugs | 2026 | 41774409 | PubTator, text mining | PubMed |
| Epilepsy and Alzheimer Disease: Epidemiologic, Clinical, Molecular, and Neuropathologic Convergences and Divergences. | Neurol Clin Pract | 2026 | 41766754 | PubTator, text mining | PubMed |
| Diagnostic and prognostic utility of serum β-synuclein in Alzheimer's disease: a longitudinal cohort study. | J Prev Alzheimers Dis | 2026 | 41763014 | PubTator, text mining | PubMed |
| Mapping spatially organized molecular and genetic signatures of schizophrenia across multiple scales in human prefrontal cortex. | bioRxiv | 2026 | 41757081 | PubTator, text mining | PubMed |
| Isogenic cortical organoids enable precision targeting of APP variant-specific pathways in Alzheimer's disease. | bioRxiv | 2026 | 41757078 | PubTator, text mining | PubMed |
| Ischemia-Induced Neurodegeneration in Glaucoma: Mechanistic Insights and Translational Opportunities for Psychoplastogen-Based Therapies. | Pharmaceuticals (Basel) | 2026 | 41754856 | PubTator, text mining | PubMed |
| Structure and Function of Ocular Proteoglycans: Essential Proteins for Vision. | Int J Mol Sci | 2026 | 41752079 | PubTator, text mining | PubMed |
| Spatiotemporal Remodeling of Presynaptic Terminals in Human Neuromuscular Junctions. | Int J Mol Sci | 2026 | 41752064 | PubTator, text mining | PubMed |
| High-throughput Genome Wide CRISPR Knock Out mechanical sort identifies genes driving metastatic cancer cell softening. | bioRxiv | 2026 | 41726982 | PubTator, text mining | PubMed |
| A Multimodal Single-Cell Epigenomic and 3D Genome Atlas of the Human Basal Ganglia. | bioRxiv | 2026 | 41726865 | PubTator, text mining | PubMed |
| Efficacy and safety of cenobamate-based combination therapy in drug-resistant epilepsy: Secondary analysis by mechanisms of action of concomitant antiseizure medications. | Seizure | 2026 | 41722460 | PubTator, text mining | PubMed |
| Anticonvulsant Therapy in Trigeminal Neuralgia: A Class-Oriented Systematic Review. | Medicines (Basel) | 2026 | 41718164 | PubTator, text mining | PubMed |
| Levetiracetam as First-Line Anti-seizure Medicine in Electrographically Confirmed Neonatal Seizures: A Literature Review. | Cureus | 2026 | 41717204 | PubTator, text mining | PubMed |
| Differentiation of neural stem cells derived from human stem cells from apical papilla into neuronal-like cells undergoing maturation via 3D-neurospheres formation and neurogenic induction. | Arch Oral Biol | 2026 | 41707579 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9900/papers?page=3